ResearchThe role of platinum-free interval in advanced endometrial cancer treatment: A real-world study of 843 patients
ResearchPredicting platinum-resistance in advanced ovarian cancer: defining patient and disease characteristics to improve treatment approaches at initiation of treatment or earlier in the course of the disease
ResearchAre patient factors associated with real-world antibody-drug conjugate outcomes in gynecologic cancers?
ResearchVariations and patterns in germline and somatic testing by age in ovarian, primary peritoneal, and fallopian tube cancer patients: a descriptive analysis in a large, real-world clinical and genetic data registry
ResearchReal-world genetic testing data of ovarian cancer patients: Informing counseling and risk reduction in patients over age seventy
ResearchAssessing the Accuracy, Completeness, and Reference Quality of GPT-4 and Google for Gynecologic Cancer Information: Comparative Quantitative Study
ResearchActionable biomarker co-expression in advanced ovarian cancer: folate receptor alpha expression and related markers
ResearchRetrospective Chart Review Indicates Earlier Age of Endometrial Cancer Diagnosis and Elevated Housing and Transportation Vulnerability in Hispanic and Native American Populations
ResearchClinical trial screening in gynecologic oncology: Defining the need and identifying best practices
ResearchAtezolizumab with chemotherapy for advanced or recurrent endometrial cancer: does targeting PD-1 or PD-L1 matter in this clinical situation?
ResearchNiraparib as First-Line Maintenance Therapy in Patients with Stage III Ovarian Cancer and No Visible Residual Disease: AR1ZE Real-World Study